Measuring Corneal Parameters
Feasibility Study - Measuring Corneal Parameters
1 other identifier
interventional
50
1 country
1
Brief Summary
The aim of this clinical investigation is to assess the feasibility of the investigational device for measuring corneal parameters of the human eye.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 22, 2026
CompletedStudy Start
First participant enrolled
May 27, 2026
CompletedFirst Posted
Study publicly available on registry
June 5, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2026
CompletedJune 5, 2026
June 1, 2026
2 months
May 22, 2026
June 1, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
The primary objective of this study is to collect a comprehensive dataset of central corneal thickness (CCT) values to assess the performance of investigational device.
Through study completion, an average of 2 months
Study Arms (4)
Measurement with the investigational device
EXPERIMENTALMeasurement with Zeiss IOL Master 700
EXPERIMENTALMeasurement with Heidelberg Anterion
EXPERIMENTALMeasurement with Nidek NT-530P
EXPERIMENTALInterventions
Measurement of corneal parameters
Measurement of corneal parameters
Eligibility Criteria
You may qualify if:
- \. Age ≥ 18 years
You may not qualify if:
- Subjects with only one functional eye
- Subjects having poor or eccentric fixation in the study eye(s)
- Central corneal scarring (that might affect the measurement result)
- Microphthalmos
- Buphthalmos
- Contact lens use (12 hours prior to measurements)
- Severe dry eyes
- Lid squeezers - blepharospasm
- Nystagmus
- Any other corneal or conjunctival pathology or condition that prevents CCT measurements
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Icare Finland Oylead
Study Sites (1)
Universitäts-Augenklinik Bonn
Bonn, North Rhine-Westphalia, 53127, Germany
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DEVICE FEASIBILITY
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 22, 2026
First Posted
June 5, 2026
Study Start
May 27, 2026
Primary Completion
July 31, 2026
Study Completion
July 31, 2026
Last Updated
June 5, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share